Industry Research Reports

Home > Reports > Service & Software > Global Artificial Intelligence in Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Artificial Intelligence in Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-09-10

Pages: 122 Pages

Report ld: 4924135

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Artificial Intelligence in Drug Discovery Market Size(US$)

CAGR 2025-2031

30.7%

Market Size,2031

USD 14,511

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 2,911 million

Market Forecast in 2031(Value)

US$ 14,511 million

CAGR

30.7%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Artificial Intelligence in Drug Discovery market size was US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14511 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.

Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient. Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.

The market for artificial intelligence (AI) in drug discovery is driven by the urgent need to accelerate and reduce the cost of developing new therapeutics, as traditional drug discovery is often slow, expensive, and prone to high failure rates. AI enables rapid identification of drug candidates, predictive modeling of drug-target interactions, and optimization of clinical trial design, significantly shortening development timelines. The explosion of biomedical data, including genomics, proteomics, and real-world clinical datasets, provides a rich foundation for AI algorithms to uncover novel insights. Additionally, rising investment from pharmaceutical companies, biotech firms, and venture capital in AI-driven platforms—combined with advances in deep learning, natural language processing, and generative models—is propelling adoption. Regulatory agencies’ increasing openness to AI-assisted drug development workflows also supports the growth of this transformative sector.

The global Artificial Intelligence in Drug Discovery market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Hardware
Software
Service

Segment by Application

Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Artificial Intelligence in Drug Discovery market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Software in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Preclinical Phase in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Artificial Intelligence in Drug Discovery value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Hardware

1.2.3 Software

1.2.4 Service

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Early Drug Discovery

1.3.3 Preclinical Phase

1.3.4 Clinical Phase

1.3.5 Regulatory Approval

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Region (2020-2025)

2.4 Global Artificial Intelligence in Drug Discovery Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Artificial Intelligence in Drug Discovery Market Size and Prospective (2020-2031)

2.5.2 Europe Artificial Intelligence in Drug Discovery Market Size and Prospective (2020-2031)

2.5.3 China Artificial Intelligence in Drug Discovery Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2020-2025)

3.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2026-2031)

3.3 Different Types Artificial Intelligence in Drug Discovery Representative Players

4 Breakdown Data by Application

4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2020-2025)

4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Artificial Intelligence in Drug Discovery Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue (2020-2025)

5.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Artificial Intelligence in Drug Discovery Revenue

5.4 Global Artificial Intelligence in Drug Discovery Market Concentration Analysis

5.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2024

5.5 Global Key Players of Artificial Intelligence in Drug Discovery Head office and Area Served

5.6 Global Key Players of Artificial Intelligence in Drug Discovery, Product and Application

5.7 Global Key Players of Artificial Intelligence in Drug Discovery, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025)

6.1.2.2 North America Artificial Intelligence in Drug Discovery Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025)

6.1.3.2 North America Artificial Intelligence in Drug Discovery Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025)

6.2.2.2 Europe Artificial Intelligence in Drug Discovery Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025)

6.2.3.2 Europe Artificial Intelligence in Drug Discovery Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025)

6.3.2.2 China Artificial Intelligence in Drug Discovery Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025)

6.3.3.2 China Artificial Intelligence in Drug Discovery Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

7 Key Players Profiles

7.1 IBM

7.1.1 IBM Company Details

7.1.2 IBM Business Overview

7.1.3 IBM Artificial Intelligence in Drug Discovery Introduction

7.1.4 IBM Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.1.5 IBM Recent Development

7.2 Exscientia

7.2.1 Exscientia Company Details

7.2.2 Exscientia Business Overview

7.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction

7.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.2.5 Exscientia Recent Development

7.3 Google(Alphabet)

7.3.1 Google(Alphabet) Company Details

7.3.2 Google(Alphabet) Business Overview

7.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Introduction

7.3.4 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.3.5 Google(Alphabet) Recent Development

7.4 Microsoft

7.4.1 Microsoft Company Details

7.4.2 Microsoft Business Overview

7.4.3 Microsoft Artificial Intelligence in Drug Discovery Introduction

7.4.4 Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.4.5 Microsoft Recent Development

7.5 Atomwise

7.5.1 Atomwise Company Details

7.5.2 Atomwise Business Overview

7.5.3 Atomwise Artificial Intelligence in Drug Discovery Introduction

7.5.4 Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.5.5 Atomwise Recent Development

7.6 Schrodinger

7.6.1 Schrodinger Company Details

7.6.2 Schrodinger Business Overview

7.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction

7.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.6.5 Schrodinger Recent Development

7.7 Aitia

7.7.1 Aitia Company Details

7.7.2 Aitia Business Overview

7.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction

7.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.7.5 Aitia Recent Development

7.8 Insilico Medicine

7.8.1 Insilico Medicine Company Details

7.8.2 Insilico Medicine Business Overview

7.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction

7.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.8.5 Insilico Medicine Recent Development

7.9 NVIDIA

7.9.1 NVIDIA Company Details

7.9.2 NVIDIA Business Overview

7.9.3 NVIDIA Artificial Intelligence in Drug Discovery Introduction

7.9.4 NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.9.5 NVIDIA Recent Development

7.10 XtalPi

7.10.1 XtalPi Company Details

7.10.2 XtalPi Business Overview

7.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction

7.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.10.5 XtalPi Recent Development

7.11 BPGbio

7.11.1 BPGbio Company Details

7.11.2 BPGbio Business Overview

7.11.3 BPGbio Artificial Intelligence in Drug Discovery Introduction

7.11.4 BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.11.5 BPGbio Recent Development

7.12 Owkin

7.12.1 Owkin Company Details

7.12.2 Owkin Business Overview

7.12.3 Owkin Artificial Intelligence in Drug Discovery Introduction

7.12.4 Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.12.5 Owkin Recent Development

7.13 CytoReason

7.13.1 CytoReason Company Details

7.13.2 CytoReason Business Overview

7.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction

7.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.13.5 CytoReason Recent Development

7.14 Deep Genomics

7.14.1 Deep Genomics Company Details

7.14.2 Deep Genomics Business Overview

7.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction

7.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.14.5 Deep Genomics Recent Development

7.15 Cloud Pharmaceuticals

7.15.1 Cloud Pharmaceuticals Company Details

7.15.2 Cloud Pharmaceuticals Business Overview

7.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction

7.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.15.5 Cloud Pharmaceuticals Recent Development

7.16 BenevolentAI

7.16.1 BenevolentAI Company Details

7.16.2 BenevolentAI Business Overview

7.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction

7.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.16.5 BenevolentAI Recent Development

7.17 Cyclica

7.17.1 Cyclica Company Details

7.17.2 Cyclica Business Overview

7.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction

7.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.17.5 Cyclica Recent Development

7.18 Verge Genomics

7.18.1 Verge Genomics Company Details

7.18.2 Verge Genomics Business Overview

7.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction

7.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.18.5 Verge Genomics Recent Development

7.19 Valo Health

7.19.1 Valo Health Company Details

7.19.2 Valo Health Business Overview

7.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction

7.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.19.5 Valo Health Recent Development

7.20 Envisagenics

7.20.1 Envisagenics Company Details

7.20.2 Envisagenics Business Overview

7.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction

7.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.20.5 Envisagenics Recent Development

7.21 Euretos

7.21.1 Euretos Company Details

7.21.2 Euretos Business Overview

7.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction

7.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.21.5 Euretos Recent Development

7.22 BioAge Labs

7.22.1 BioAge Labs Company Details

7.22.2 BioAge Labs Business Overview

7.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction

7.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.22.5 BioAge Labs Recent Development

7.23 Iktos

7.23.1 Iktos Company Details

7.23.2 Iktos Business Overview

7.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction

7.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.23.5 Iktos Recent Development

7.24 BioSymetrics

7.24.1 BioSymetrics Company Details

7.24.2 BioSymetrics Business Overview

7.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction

7.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.24.5 BioSymetrics Recent Development

7.25 Evaxion Biotech

7.25.1 Evaxion Biotech Company Details

7.25.2 Evaxion Biotech Business Overview

7.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Introduction

7.25.4 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.25.5 Evaxion Biotech Recent Development

7.26 Aria Pharmaceuticals, Inc

7.26.1 Aria Pharmaceuticals, Inc Company Details

7.26.2 Aria Pharmaceuticals, Inc Business Overview

7.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction

7.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025)

7.26.5 Aria Pharmaceuticals, Inc Recent Development

8 Artificial Intelligence in Drug Discovery Market Dynamics

8.1 Artificial Intelligence in Drug Discovery Industry Trends

8.2 Artificial Intelligence in Drug Discovery Market Drivers

8.3 Artificial Intelligence in Drug Discovery Market Challenges

8.4 Artificial Intelligence in Drug Discovery Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Artificial Intelligence in Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Artificial Intelligence in Drug Discovery Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Artificial Intelligence in Drug Discovery Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Artificial Intelligence in Drug Discovery Revenue Share by Region (2020-2025)

Table 6. Global Artificial Intelligence in Drug Discovery Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Artificial Intelligence in Drug Discovery Revenue Share Forecast by Region (2026-2031)

Table 8. Global Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2020-2025)

Table 10. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2020-2025)

Table 15. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Artificial Intelligence in Drug Discovery Application

Table 18. Global Artificial Intelligence in Drug Discovery Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Artificial Intelligence in Drug Discovery Market Share by Players (2020-2025)

Table 20. Global Top Artificial Intelligence in Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Drug Discovery as of 2024)

Table 21. Ranking of Global Top Artificial Intelligence in Drug Discovery Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Artificial Intelligence in Drug Discovery Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Artificial Intelligence in Drug Discovery, Headquarters and Area Served

Table 24. Global Key Players of Artificial Intelligence in Drug Discovery, Product and Application

Table 25. Global Key Players of Artificial Intelligence in Drug Discovery, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Artificial Intelligence in Drug Discovery Revenue Market Share by Company (2020-2025)

Table 29. North America Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Artificial Intelligence in Drug Discovery Revenue Market Share by Company (2020-2025)

Table 33. Europe Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Artificial Intelligence in Drug Discovery Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Artificial Intelligence in Drug Discovery Revenue Market Share by Company (2020-2025)

Table 37. China Artificial Intelligence in Drug Discovery Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Artificial Intelligence in Drug Discovery Market Size by Application (2020-2025) & (US$ Million)

Table 39. IBM Company Details

Table 40. IBM Business Overview

Table 41. IBM Artificial Intelligence in Drug Discovery Product

Table 42. IBM Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 43. IBM Recent Development

Table 44. Exscientia Company Details

Table 45. Exscientia Business Overview

Table 46. Exscientia Artificial Intelligence in Drug Discovery Product

Table 47. Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 48. Exscientia Recent Development

Table 49. Google(Alphabet) Company Details

Table 50. Google(Alphabet) Business Overview

Table 51. Google(Alphabet) Artificial Intelligence in Drug Discovery Product

Table 52. Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 53. Google(Alphabet) Recent Development

Table 54. Microsoft Company Details

Table 55. Microsoft Business Overview

Table 56. Microsoft Artificial Intelligence in Drug Discovery Product

Table 57. Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 58. Microsoft Recent Development

Table 59. Atomwise Company Details

Table 60. Atomwise Business Overview

Table 61. Atomwise Artificial Intelligence in Drug Discovery Product

Table 62. Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 63. Atomwise Recent Development

Table 64. Schrodinger Company Details

Table 65. Schrodinger Business Overview

Table 66. Schrodinger Artificial Intelligence in Drug Discovery Product

Table 67. Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 68. Schrodinger Recent Development

Table 69. Aitia Company Details

Table 70. Aitia Business Overview

Table 71. Aitia Artificial Intelligence in Drug Discovery Product

Table 72. Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 73. Aitia Recent Development

Table 74. Insilico Medicine Company Details

Table 75. Insilico Medicine Business Overview

Table 76. Insilico Medicine Artificial Intelligence in Drug Discovery Product

Table 77. Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 78. Insilico Medicine Recent Development

Table 79. NVIDIA Company Details

Table 80. NVIDIA Business Overview

Table 81. NVIDIA Artificial Intelligence in Drug Discovery Product

Table 82. NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 83. NVIDIA Recent Development

Table 84. XtalPi Company Details

Table 85. XtalPi Business Overview

Table 86. XtalPi Artificial Intelligence in Drug Discovery Product

Table 87. XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 88. XtalPi Recent Development

Table 89. BPGbio Company Details

Table 90. BPGbio Business Overview

Table 91. BPGbio Artificial Intelligence in Drug Discovery Product

Table 92. BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 93. BPGbio Recent Development

Table 94. Owkin Company Details

Table 95. Owkin Business Overview

Table 96. Owkin Artificial Intelligence in Drug Discovery Product

Table 97. Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 98. Owkin Recent Development

Table 99. CytoReason Company Details

Table 100. CytoReason Business Overview

Table 101. CytoReason Artificial Intelligence in Drug Discovery Product

Table 102. CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 103. CytoReason Recent Development

Table 104. Deep Genomics Company Details

Table 105. Deep Genomics Business Overview

Table 106. Deep Genomics Artificial Intelligence in Drug Discovery Product

Table 107. Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 108. Deep Genomics Recent Development

Table 109. Cloud Pharmaceuticals Company Details

Table 110. Cloud Pharmaceuticals Business Overview

Table 111. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product

Table 112. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 113. Cloud Pharmaceuticals Recent Development

Table 114. BenevolentAI Company Details

Table 115. BenevolentAI Business Overview

Table 116. BenevolentAI Artificial Intelligence in Drug Discovery Product

Table 117. BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 118. BenevolentAI Recent Development

Table 119. Cyclica Company Details

Table 120. Cyclica Business Overview

Table 121. Cyclica Artificial Intelligence in Drug Discovery Product

Table 122. Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 123. Cyclica Recent Development

Table 124. Verge Genomics Company Details

Table 125. Verge Genomics Business Overview

Table 126. Verge Genomics Artificial Intelligence in Drug Discovery Product

Table 127. Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 128. Verge Genomics Recent Development

Table 129. Valo Health Company Details

Table 130. Valo Health Business Overview

Table 131. Valo Health Artificial Intelligence in Drug Discovery Product

Table 132. Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 133. Valo Health Recent Development

Table 134. Envisagenics Company Details

Table 135. Envisagenics Business Overview

Table 136. Envisagenics Artificial Intelligence in Drug Discovery Product

Table 137. Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 138. Envisagenics Recent Development

Table 139. Euretos Company Details

Table 140. Euretos Business Overview

Table 141. Euretos Artificial Intelligence in Drug Discovery Product

Table 142. Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 143. Euretos Recent Development

Table 144. BioAge Labs Company Details

Table 145. BioAge Labs Business Overview

Table 146. BioAge Labs Artificial Intelligence in Drug Discovery Product

Table 147. BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 148. BioAge Labs Recent Development

Table 149. Iktos Company Details

Table 150. Iktos Business Overview

Table 151. Iktos Artificial Intelligence in Drug Discovery Product

Table 152. Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 153. Iktos Recent Development

Table 154. BioSymetrics Company Details

Table 155. BioSymetrics Business Overview

Table 156. BioSymetrics Artificial Intelligence in Drug Discovery Product

Table 157. BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 158. BioSymetrics Recent Development

Table 159. Evaxion Biotech Company Details

Table 160. Evaxion Biotech Business Overview

Table 161. Evaxion Biotech Artificial Intelligence in Drug Discovery Product

Table 162. Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 163. Evaxion Biotech Recent Development

Table 164. Aria Pharmaceuticals, Inc Company Details

Table 165. Aria Pharmaceuticals, Inc Business Overview

Table 166. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product

Table 167. Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2020-2025) & (US$ Million)

Table 168. Aria Pharmaceuticals, Inc Recent Development

Table 169. Artificial Intelligence in Drug Discovery Market Trends

Table 170. Artificial Intelligence in Drug Discovery Market Drivers

Table 171. Artificial Intelligence in Drug Discovery Market Challenges

Table 172. Artificial Intelligence in Drug Discovery Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Artificial Intelligence in Drug Discovery Product Picture

Figure 2. Global Artificial Intelligence in Drug Discovery Market Share by Type: 2024 VS 2031

Figure 3. Hardware Features

Figure 4. Software Features

Figure 5. Service Features

Figure 6. Global Artificial Intelligence in Drug Discovery Market Share by Application: 2024 VS 2031

Figure 7. Early Drug Discovery

Figure 8. Preclinical Phase

Figure 9. Clinical Phase

Figure 10. Regulatory Approval

Figure 11. Artificial Intelligence in Drug Discovery Report Years Considered

Figure 12. Global Artificial Intelligence in Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Artificial Intelligence in Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Region: 2020 VS 2024

Figure 15. North America Artificial Intelligence in Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Europe Artificial Intelligence in Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. China Artificial Intelligence in Drug Discovery Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Global Artificial Intelligence in Drug Discovery Market Share by Players in 2024

Figure 19. Global Top Artificial Intelligence in Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Drug Discovery as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Artificial Intelligence in Drug Discovery Revenue in 2024

Figure 21. North America Artificial Intelligence in Drug Discovery Market Share by Type (2020-2025)

Figure 22. North America Artificial Intelligence in Drug Discovery Market Share by Application (2020-2025)

Figure 23. Europe Artificial Intelligence in Drug Discovery Market Share by Type (2020-2025)

Figure 24. Europe Artificial Intelligence in Drug Discovery Market Share by Application (2020-2025)

Figure 25. China Artificial Intelligence in Drug Discovery Market Share by Type (2020-2025)

Figure 26. China Artificial Intelligence in Drug Discovery Market Share by Application (2020-2025)

Figure 27. IBM Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 28. Exscientia Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 29. Google(Alphabet) Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 30. Microsoft Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 31. Atomwise Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 32. Schrodinger Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 33. Aitia Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 34. Insilico Medicine Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 35. NVIDIA Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 36. XtalPi Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 37. BPGbio Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 38. Owkin Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 39. CytoReason Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 40. Deep Genomics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 41. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 42. BenevolentAI Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 43. Cyclica Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 44. Verge Genomics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 45. Valo Health Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 46. Envisagenics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 47. Euretos Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 48. BioAge Labs Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 49. Iktos Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 50. BioSymetrics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 51. Evaxion Biotech Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 52. Aria Pharmaceuticals, Inc Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Artificial Intelligence in Drug Discovery in 2031? zhanKai

The global market size of Artificial Intelligence in Drug Discovery in 2031 was 14511 Million USD.

Which companies rank high in the global Artificial Intelligence in Drug Discovery market? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Artificial Intelligence in Drug Discovery market size from 2025 to 2031? shouQi

What was the global market size of Artificial Intelligence in Drug Discovery in 2025? shouQi

Related Reports

Global Artificial Intelligence in Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artificial Intelligence in Drug Discovery market size was US$ 2911 million in 2025 and is forecast to reach a readjusted size of US$ 18520 million by 2032 with a CAGR of 30.7% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 130
USD 4250.00
(Single User License)
Global Artificial Intelligence in Drug Discovery Market Research Report 2026
The global Artificial Intelligence in Drug Discovery market was valued at US$ 2911 million in 2025 and is anticipated to reach US$ 18520 million by 2032, at a CAGR of 30.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 176
USD 2900.00
(Single User License)
Artificial Intelligence in Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2911 million in 2025 and is projected to reach US$ 18520 million, growing at a CAGR of 30.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 169
USD 3950.00
(Single User License)
Global Artificial Intelligence in Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ 2281 million in 2024 to US$ 14511 million by 2031, at a CAGR of 30.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-13
Pages: 185
USD 4900.00
(Single User License)
Artificial Intelligence in Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14511 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 168
USD 3950.00
(Single User License)
Global Artificial Intelligence in Drug Discovery Market Research Report 2025
The global market for Artificial Intelligence in Drug Discovery was valued at US$ 2281 million in the year 2024 and is projected to reach a revised size of US$ 14511 million by 2031, growing at a CAGR of 30.7% during the forecast period.
Published Date: 2025-08-13
Pages: 112
USD 2900.00
(Single User License)
Artificial Intelligence in Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14510 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 179
USD 3950.00
(Single User License)
Global Artificial Intelligence in Drug Discovery Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Published Date: 2024-04-17
Pages: 198
USD 5600.00
(Single User License)
Global Artificial Intelligence in Drug Discovery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2030
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Published Date: 2024-04-07
Pages: 125
USD 4900.00
(Single User License)

Global Artificial Intelligence in Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artificial Intelligence in Drug Discovery market size was US$ 2911 million in 2025 and is forecast to reach a readjusted size of US$ 18520 million by 2032 with a CAGR of 30.7% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 130
USD 4250.00 (Single User License)
Global Artificial Intelligence in Drug Discovery Market Research Report 2026
The global Artificial Intelligence in Drug Discovery market was valued at US$ 2911 million in 2025 and is anticipated to reach US$ 18520 million by 2032, at a CAGR of 30.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 176
USD 2900.00 (Single User License)
Artificial Intelligence in Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2911 million in 2025 and is projected to reach US$ 18520 million, growing at a CAGR of 30.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 169
USD 3950.00 (Single User License)
Global Artificial Intelligence in Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ 2281 million in 2024 to US$ 14511 million by 2031, at a CAGR of 30.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-13
Pages: 185
USD 4900.00 (Single User License)
Artificial Intelligence in Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14511 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 168
USD 3950.00 (Single User License)
Global Artificial Intelligence in Drug Discovery Market Research Report 2025
The global market for Artificial Intelligence in Drug Discovery was valued at US$ 2281 million in the year 2024 and is projected to reach a revised size of US$ 14511 million by 2031, growing at a CAGR of 30.7% during the forecast period.
Published: 2025-08-13
Pages: 112
USD 2900.00 (Single User License)
Artificial Intelligence in Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Drug Discovery was estimated to be worth US$ 2281 million in 2024 and is forecast to a readjusted size of US$ 14510 million by 2031 with a CAGR of 30.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 179
USD 3950.00 (Single User License)
Global Artificial Intelligence in Drug Discovery Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Published: 2024-04-17
Pages: 198
USD 5600.00 (Single User License)
Global Artificial Intelligence in Drug Discovery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Published: 2024-04-16
Pages: 186
USD 5900.00 (Single User License)
Global Artificial Intelligence in Drug Discovery Market Insights, Forecast to 2030
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Published: 2024-04-07
Pages: 125
USD 4900.00 (Single User License)